Efficacy of Escitalopram in Treating Pediatric Anxiety

Escitalopram has been shown to be highly effective in reducing anxiety symptoms in children and adolescents diagnosed with generalized anxiety disorder (GAD). In a study involving participants aged seven to seventeen, the medication was found to be significantly superior to placebo after eight weeks of treatment. This research indicates important advancements in understanding the efficacy of selective serotonin reuptake inhibitors (SSRIs) for younger populations, extending the known benefits into pre-adolescent children. Clinicians now have a reliable option for managing GAD symptoms in younger patients who often experience significant disruptions in their daily lives.